Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention1: Dantabija, Haridra and Zingiber officinale Lozenges: Intervention group will recieve standard treatment plus chewable tablets containing ginger, turmeric and pomegranate extracts (Danta
Sponsors
Alchem Phytoceuticals
Eligibility
Inclusion criteria
Inclusion criteria: a)COVID-19 RT-PCR test/ COVID-19 antigen test/COVID-19 TRUNAT test Positive b) All Males and Females between 5 to 70 years. c) Having history of dry cough/fever/malaise/rhinorrhea/New loss of taste and smell/Gastrointestinal upset. d) Patients who can take medicines orally. e) No Oxygen requirement/ Oxygen requirement of less than 5L/minute.
Exclusion criteria
Exclusion criteria: a) Oxygen requirement of more than 5L/minute. b) Patients who are on Ventilatory support. c) Who cannot take medicines by oral route? d) Patients who are on dialysis. e) Age less than five years and more than 70 years. f) Patients taking any other Ayurvedic supplement.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To Evaluate efficacy of combination of Dantabija 20mg, Haridra 50mg and Zingiber officinale 5mg in controlling COVID-19 Disease We will measure following parameters 1)COVID-19 RT PCR test 2) Complete Blood Count 3)C reactive protein and serum Ferritin 4)IL-2 and IL-6. Timepoint: 5th Day and 10th day from start of Intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| To Check reduction in duration of COVID-19 Disease with use of combination of Dantabija 20mg, Haridra 50mg and Zingiber officinale 5mg in controlling COVID-19 Disease measured by COVID-19 RT PCR test becoming negative.Timepoint: Five and ten days from start of intervention. | — |
Countries
India
Contacts
Public ContactDr Yogesh Kumar
AIIMS Patna
Outcome results
None listed